Select Page

Cytomegalovirus (CMV) infection is the common herpes virus infection having different symptoms which occurs in all ages of people around the world. Cytomegalovirus (CMV) infection is a communicable and easily prone through the body fluids like urine, saliva, blood, breast milk and semen. The infection may spread fast from urine or saliva from people who are infected with CMV having virus in their bodily fluids. The disease can transmit from pregnant to baby during delivery. Organ transplant and Blood transfusion are the other way for the transmission of the disease.
The infection can be diagnosed through serological testing methods such as Enzyme-linked immunoassay test. Many of the cases of CMV goes undiagnosed in early stage of infection thus the awareness about the infection is most important factor. According to the Centers for Disease Control and Prevention (CDC), in U.S., each year around 150 infants are born with cytomegalovirus infections and few of them have long term health problems.

Cytomegalovirus infection market: Treatment approach
Cytomegalovirus infection treatment market is mainly propelling by the rise in the prevalence of CMV infections, growing awareness about herpes disease, pipeline drugs which are promising by key market players for the treatment of CMV infection. Moreover, rise in the support of government, and development of healthcare infrastructure are anticipated to fuel the growth of CMV infection treatment market. However, recent expiries of patented drugs, generic drugs that are available for the treatment like Ganciclovir & Foscarnet are anticipated to hamper the market growth of cytomegalovirus infection treatment.

For request sample:

Cytomegalovirus infection market: Regional approach
Region wise, the global cytomegalovirus infection market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East and Africa. The growth of CMV virus is attributed to the increasing awareness regarding the herpes virus and increasing diagnosis rate in developed region such as North America and Europe. Similarly, the government initiatives for the awareness regarding rate disease, growing healthcare expenditure and escalating disposable income are few of the factors responsible the market growth in Asia-Pacific.
Some of the key players in cytomegalovirus infection market are
• F. Hoffmann-La Roche AG (Switzerland)
• GlaxoSmithKline plc (U.K.)
• Merck & Co., Inc. (U.S.)
• AiCuris Anti-infective Cures GmbH (Germany)
• Vical, Inc. (U.S.)
• Chimerix, Inc. (U.S.)
• ViroPharma (U.S.),

Precision Business Insights (PBI) in its report titled “Cytomegalovirus Infection Treatment Market”: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 20XX-20XX and Forecast 20XX-20XX” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast.
The global cytomegalovirus infection market can be classified on the basis of drug class, infection, distribution channel, and geography.

Based on drug class, the global cytomegalovirus infection market is segmented into the following:
• Antiviral drugs
o Foscarnet
o Cytovene
o Vistide
o Others

Based on infection, the global cytomegalovirus infection market is segmented into the following
• Retinitis
• Pneumonia
• Gastroenteritis
• Others (Mouth Ulcers, Pharyngitis, etc.)

Based on distribution channel, the global cytomegalovirus infection market is segmented into the following:
• Hospital Pharmacies
• Retail Pharmacies
• Others

For more information:

About precision business insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

Contact to Precision Business Insights

Kemp House,
152 – 160 City Road,
London EC1V 2NX
Toll Free (US): +1-866-598-1553
Website @